SIAPS Guinea was recently featured on the website, africaguinee.com, in recognition of its work training staff at the Central Pharmacy of Guinea (PCG) in best practices for pharmaceutical management. PGC’s Director General, Dr. Moussa Konaté, opened the training sessions by emphasizing the responsibility of the Central Pharmacy to properly manage essential generic medicines to ensure optimum health … Read more
Weak health information systems are a bottleneck for effective tuberculosis (TB) control. The emergence of drug‐resistant TB (DR-TB) increases the need for tools that allows effectively managed information on diagnosing, prescribing practices, treatment, and rational medicines use, while also supporting uninterrupted availability of anti-TB medicines. e-TB Manager is a system-strengthening, comprehensive electronic web-based information system, developed … Read more
By: Jean Bedel Evi Antiretroviral (ARV) medicines are a matter of life or death for people who are HIV-positive. In West Africa, the US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) is working to make sure people have uninterrupted access to these life-saving medicines. With support provided by the US President’s Emergency Plan … Read more
By Emmanuel Nfor The availability of new and essential medicines and other health technologies to treat life-threatening illnesses have helped millions of people lead long and productive lives. However, global availability does not necessarily mean access by the end-consumer to these lifesaving health products in low-and middle-income countries. Effective supply chains are needed to deliver … Read more
In commemoration of World Malaria Day, SIAPS joins the global health community in recognizing the remarkable strides that have been made in the fight against malaria. More than ever, people in malaria-endemic countries, especially those who are particularly vulnerable like mothers and children, are receiving effective prevention, diagnosis, and treatment services and have better access … Read more
SIAPS program is excited to announce the launch of a new version of QuanTB, version 1.0.2, an electronic forecasting, quantification, and early warning tool designed to improve procurement processes, ordering, and planning for tuberculosis (TB) treatment. QuanTB is now available in 6 languages: English, Russian, French, Spanish, Portuguese, and Chinese. In addition, this new version … Read more
Today SIAPS joins people around the world commemorating World TB Day. This year’s theme, “Reach the 3 million,” is a call worldwide to find, treat and cure the undetected TB cases left behind in the fight against TB. Read about the first Conference on Pharmaceutical Management for TB and M/XDR-TB for the WHO European Region, … Read more
The highest rate of multi-drug resistant (M) and extensively drug-resistant (XDR) cases of tuberculosis (TB) is found in the WHO European Region. The Consolidated Action Plan to Prevent and Combat M/XDR-TB in the WHO European Region specifies that, by the end of 2013, all member states assure provision of an interrupted supply of quality first- … Read more
Successfully combating the tuberculosis (TB) epidemic requires that national TB programs (NTPs) prevent new infections and ensure that current patients are cured. Although the treatment for drug-sensitive TB is very effective, curing the disease requires that patients adhere to a strict daily regimen of multiple pills for six to nine months. Adding to the challenge … Read more
All medicines carry some risk of adverse events; although certain risks are identified when medicines are tested during clinical trials, others aren’t recognized until after the medicine is on the market and has been used in “real world” settings. Adverse events not only endanger the health of patients, but if not well managed, they may … Read more
